Abbott Showcases Cutting-Edge Health Technologies at CIIE Under the Theme 'Empowering a Healthier Future with Life-Changing Innovations'

Source: Instrument Family, unauthorized reproduction is prohibited, and reprinting is allowed 24 hours later.

Recently,器械之家has learned that Abbott, a global leading healthcare company, attended the CIIE for the third consecutive year this year. This time, it is showcasing under the theme of “Life Technology Empowers a Healthy Future" as the theme to participate in the CIIE.

In550 square metersNewly UpgradedBoothFull DisplayCovering diagnosis, medical devices, nutritional products, and pharmaceuticalsDiversified innovation achievements in core business areas, focusing on more personalized and precise health solutions throughout the entire life cycle.

01

Global Healthcare Industry

Leader Abbott

Abbott, as a global leader in the healthcare industry, helps people live better at all stages of life. Abbott brings cutting-edge technology to health and life.Leading products span across medical and health fields such as diagnostics, medical devices, nutritional products, and pharmaceuticals.

AbbottFounded in 1888, starting from a pharmacy,Entering the healthcare field, after a century of development, Abbott Laboratories has achieved its current leading position in the healthcare industry.

From nutritional products, diagnostic products, and medical devices to pharmaceuticals,Abbott, with its leading cardiovascular stents and treatment technologies, as well as high-quality scientific nutrition products suitable for all stages of life,Technologies for alleviating chronic pain and improving mobility, along with advanced diagnostics and pharmaceutical technologies, are dedicated to helping people live healthier lives.

Abbott in109,000 employees globally, helping people in more than 160 countries and regions around the world live life to the fullest. AbbottWith over 6,000 employees in China, headquartered in Shanghai.

Abbott Values Development in China

Since 2010, Abbott has continued to invest in the Chinese market, developing, manufacturing, and marketing products in China.Covering nutritional products, pharmaceuticals, medical devices, and diagnostic products,Ensure that their products and services fully meet the comprehensive needs from disease prevention to diagnosis and from treatment to recovery.

In 2014,Abbott's Advanced Nutrition Plant, Invested $230 Million in Jiaxing, Officially OpensThis is their largest investment project in China, showcasing Abbott's strong ambition to improve the health of all Chinese people.

Abbott values the R&D capabilities in China,They not only established a research and development center in Shanghai but also founded the Shanghai Children's Medical Center with their partners. Through local clinical trials and operations, Abbott China's R&D capabilities have significantly improved.In terms of medical innovation, we collaborate closely with other global R&D centers to jointly address worldwide medical challenges.

Abbott Continues to Drive Innovative Breakthroughs in Prevention, Diagnosis, and Treatment, committed to transforming lives through cutting-edge technologies and products.Envisioning the transformation of healthcare technology to meet the urgent healthcare needs across regions, supporting "Healthy China."

02

Highlights of the Exhibits at This Exhibition

Since participating in the exhibition, Abbott has successivelyShowcased dozens of cutting-edge life science technologies and innovative products making their Asian debut or China debut.。

Thanks to the platform effect and spillover effect of the CIIE, many of them have been successfully applied in China.Provided intelligent, precise, and efficient solutions in the field of chronic diseases such as cardiovascular and diabetes,

It is worth looking forward to.At this year's exhibition, Abbott will continue to unveil groundbreaking innovations in life science, revolutionizing and leading the treatment of major diseases.Enable people to live healthier and longer lives.

The products and devices Abbott plans to exhibit this time include: MitraClip Transcatheter Mitral Valve Clip, ID Now Isothermal Nucleic Acid Amplification Test Instrument, LibreLinkUp App, and several other innovative solutions.Abbott is currently aware of the planned exhibition equipment, with specific details as follows:：

MitraClip

It is reported that this product is "MitraClip Transcatheter Mitral Valve Clip”。

This product is world-leading.Transcatheter Mitral Valve Clip for Minimally Invasive Treatment of Mitral Regurgitation Enables Rapid Detection。

ID Now

It is reported that this product is "ID Now Isothermal Nucleic Acid Amplification Testing Instrument”。

Abbott also broughtAdopted revolutionary molecular amplification technologyID Now Isothermal Nucleic Acid Amplification Test Instrument.It is compact and portable, easy to operate, and in the sampleIn cases where the viral or bacterial load is low, the sample can be amplified hundreds of millions of times, allowing test results to be obtained within minutes.

LibreLink APP

It is reported that this product is "LibreLinkUp APP”。

"Scan with your phone to measure blood sugar" - Abbott's FreeStyle Libre flash glucose monitoring system and the digital products of the FreeStyle family, among other life science exhibits,Achieve "Blood Sugar Testing Without Finger Pricks"Benefiting a large number of patients and medical institutions.

03

Highlights of Previous CIIE

After learning about Abbott's participation information for this year, let's take a look at Abbott's highlights from previous China International Import Expos (CIIE). Leveraging the powerful market aggregation effect brought by the CIIE as an open cooperation platform, during the fourth CIIE;

AbbottA Series of Wonderful Activities: Abbott Diabetes Care Showcases Latest Product, FreeStyle Libre, at CIIE New Products Event, Drawing Media AttentionIn addition, the nutrition business has also partnered with JD.com to showcase the Similac Organic Series infant formula.

At the same time, Vice President of Abbott Core Diagnostics globally,Chen Ying, General Manager of Abbott China, said: "Since the first participation in the CIIE,Abbott's intelligent life technology products have successively emerged from the 'four-leaf clover'.，Effectively help those in need.These heartwarming moments deeply remind us that the CIIE is not only a platform for showcasing achievements but also a window for interactive exchange.

Participating again, we will showcase diversified healthcare solutions required by the Chinese market, based on our deep insights into China's healthcare industry in recent years.At this CIIE, we also look forward to having more opportunities to connect with partners from all sectors, helping to achieve the goal of Healthy China.。”

— —

The above are the products Abbott plans to exhibit this time. The CIIE has now entered the countdown stage. For more details, let's look forward to the live broadcast of the Medical Device Family at the CIIE. There will be 3 days of live streaming, so stay tuned.